The precise overall contribution of Stau1 to the DM1 phenotype thus remains to be fully explored, but our results to date strongly indicate that Stau1 needs to be considered amongst the gene products that modulate the complex DM1 pathophysiology and its response to future therapeutic interventions. The gene discussed is STAU1; the disease is myotonic dystrophy type 1.